Technical Description
This invention involves a glycogen-conjugated polymeric micelle nano-formulation for targeted drug delivery, enhancing efficacy and stability for breast cancer treatment.
Problems Addressed
- Glutaits Particle Inhibition
- Ineffective Drug Release
- Poor Encapsulation
- Low Efficacy
Tech Features
- Nano-formulated Micelles
- Reduced Drug Resistance
- Enhanced Efficacy
- Effective Therapy
- Biocompatible Polymer
Target Audience
- Pharmaceutical Industry
- Biotechnology Sector
- Diagnostic Centre
- Healthcare & Hospitals
Tech ID: P35-1905
TRL 4
Patent Status: Published
Available For Exclusive and Non-exclusive License
